Académique Documents
Professionnel Documents
Culture Documents
THE GUT
Dr. Loquiano
December 17, 2014
TigbaONE!
NUCLEAR MEDICINE
Medical specialty that uses SAFE, PAINLESS and
COST-EFFECTIVE techniques to both image the body
and treat disease.
A sensitive way to gather information that may
otherwise be unavailable, require surgery, or
necessitate more expensive and risky diagnostic
tests.
Body is imaged from the inside out
Radiotracers, in the form of radiopharmaceuticals,
administered internally (intravenous, inhalation or
orally)
*unlike other procedures, it does not need the use of
dyes so you dont have to check kidney functions like
creatinine level after administration.
Diagnostic inference is gained by recording the
distribution of radioactive materials in the body
Sequence of events - to understand nuclear med
procedures
Physics of radioactivity
Process of detecting radiation
Selection of appropriate radiopharmaceuticals
Uptake and distribution of radiopharmaceuticals in
health and disease
TYPES OF RADIATION IMPORTANT IN NUCLEAR
MEDICINE
Gamma rays photons originating in the nucleus
Characteristic x-rays photons originating outside
the nucleus
Negatrons (beta particles) high radiation dose; ex.
Iodine-131 for tx of thyroid cancer and
hyperthyroidism
Positrons (beta+ particles)
Alpha particles helium nuclei; undesirable in
diagnostic applications due to high radiation to
patient
Gamma camera - Specialized equipment that detects,
records and process radioactivity emanating from the
patient in order to create scintigraphic images does
not emit radiation unlike X-ray machines
Conversion
Factor
Joule (J)
107
Becquerel
(Bq)
3.7x1010
Radiation
Absorbed
Dose
Rad
Gray (Gy)
100
Radiation
Exposure
Dose
Equivalent
man
Work
Erg
100
Common Radionucleotides
RADIONUCLIDE HALF-LIFE
TARGET
ORGAN/DISEASE
Technetium99m
6 hrs
Thyroid, heart,
bone,
lungs,
kidneys
Iodine-131
8 days
Thyroid
Thallium-201
73 hrs
Heart
Gallium-67
78 hrs
lymphoma
in radionuclides with high half-life, increase fluid intake
to enhance radionuclide excretion so that before 60 hrs
or at least 24 hours, radioactive materials are totally
excreted
Technetium 99m (99mTc)
ideal radionuclide
>70% nuclear imaging procedures
no particulate emission
6-hour t1/2
predominant 140-keV photon
rapidly concentrates in salivary glands, choroid
plexus, thyroid gland, gastric mucosa,
functioning breast tissue, placenta
excretion - GIT, kidneys and GUT
Nuclear Medicine Procedures
Identify abnormalities very early in the progression
of a disease long before some medical problems
are apparent with other diagnostic tests
e.g. breast cancer px complaining of back pain may
have normal CXR but when subjected to bone scan,
early changes in bones may show signs of metastasis
Early detection allows disease to be treated early in
its course when there may be a more successful
prognosis
Is it safe? Yes, it is among the safest means
available.
How much radiation does a Px Receive for a Nuclear
Med Procedure?
Comparable to, or often times, less than that of a
diagnostic X-Ray
Patient receives about the same amount of radiation
as that required in a few months of normal leaving
e.g. traveling from Ph to US/Europe through airplane
exposes you to more UV Radiation compared to that
of a nuclear medicine procedure
Radiopharmaceuticals
1. Glomerular Filtration Rate agents should:
completely filtered by glomerulus
not be protein-bound (cant be
filtered if it is)
not be resorbed nor secreted by renal
tubules
be excreted only by kidney (so that
plasma sampling techniques can be
used rather than urine sampling
a.
99m
Tc-DTPA
(technetium
99m
diethylenetriamine pentaacetic acid)
-used in the local setting
completely eliminated by glomerular
filtration; no tubular secretion occurs
- meets the requirement for measuring GFR
except for the 3-5% that is protein-bound
b. Chromium 51 EDTA
- GFR slightly lower than inulin
c. I123/I131 iodothalamate
-radioactive contrast
d. I131 diatrizoate
-radiographic contrast used in xrays and CT
scans
2. Tubular agents
ideal agent for measuring effective renal
plasma flow (ERPF)
Also used for renal function
In the local setting, we only have GFR
radiopharmaceutical agents
a. 131I OIH (Iodine 131 orthoiodohippurate)
chemically similar to paraaminohippuric acid
(PAH)
gold standard for measurement of ERPF
b.
99m
Tc
MAG3
(Technetium
99m
mercaptoacetyltriglycine) 99mTc replacement
for IOH; excreted by PCT like OIH, not retained
in parenchyma; lower radiation dose; superior
quality of renal images than IOH & DTPA
3. Parenchymal Agent
a. 99mTc
DMSA
(Technetium
99m
dimercaptosuccinic acid) taken up by renal
cortex in proximal convoluted tubule; 90%
protein
bound
preventing
significant
glomerular filtration
Technique for doing Nuclear Renal Study
1. Flow study:
-rapid sequential images every 2 seconds for
30-60 seconds
-10-15 mCi of 99mTc-DTPA or 5-10 mCi MAG3
via bolus injection
Unit of radiation is in Curie (Ci). What
is being given to patients is only in
milliCuries (mCi).
2. Excretion study:
-serial 3-minute images for 30 minutes
-Adequate hydration; let px void before the
study
full bladder can simulate upper tract
obstruction if the px is dehydrated-will give
falsely low results
Different types of nuclear medicine studies for kidney
diseases
1. Glomerular Filtration Rate used to monitor
urine flow in mL/min (normal: 80-120mL/min);
goes lower as the person ages; measured
according to the patients height and weight
and body surface area; lasts for 6min
2. Basic Renal Scan native and transplanted
kidneys; usual renal scan; assess renal function
and urodynamics or the excretion of the
kidneys; lasts for 20min; patient has to wait for
one hour before extraction of the blood and for
the third hour for another re-extraction
3. Diuretic renal scan to diagnose or exclude
urinary tract obstruction; diuretic-augmented
renal scan; we give diuretics like furosemide
and observe whether patients excretion
improves with diuresis; if it improves, it means
B. Excretory phase
*in
NORMAL RENAL CORTEX SCAN
Notetakers:
Editor:
-
Arielle
Boni
Jan
Lauren